Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E protects against NMDA excitotoxicity.

Mitsuo Aono1, Yoonki Lee, Elfrida R Grant

  • 1Multidisciplinary Neuroprotection Laboratory, Duke University Medical Center, Durham, North Carolina 27710, USA.

Neurobiology of Disease
|December 4, 2002
PubMed
Summary

Apolipoprotein E (apoE) offers partial protection against glutamate excitotoxicity in neurons. This neuroprotective effect may reduce central nervous system damage during ischemic events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CN-105 in Participants with Acute Supratentorial Intracerebral Hemorrhage Trial in Singapore (S-CATCH): A Phase 2b, Randomized, Double-blind, Placebo-Controlled Trial.

Neurocritical care·2026
Same author

Apolipoprotein E Mimetic Peptide CN-105 and Postoperative Delirium in Older Patients: The Phase 2 MARBLE Randomized Clinical Trial.

JAMA network open·2026
Same author

Association of blood pressure variability with clinical and biomarker outcomes in moderate to severe TBI: A TRACK-TBI study.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

A Novel Anti-Inflammatory Small Molecule MW189 Reduces Microglial Activation and Improves Functional Outcomes in a Murine Model of Subarachnoid Hemorrhage.

Neurocritical care·2026
Same author

Methodological considerations in PISCES 3: a randomized, placebo-controlled study of intracerebral stem cells in subjects with disability following an ischemic stroke.

Frontiers in stroke·2026
Same author

An atypical non-ribosomal peptide cyclase catalyzing homochiral coupling with cyclic amine nucleophile.

The Journal of antibiotics·2025

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Endogenous apolipoprotein E (apoE) plays a role in brain injury response to ischemia.
  • Glutamate excitotoxicity is a key mechanism in neuronal damage during ischemic stroke.

Purpose of the Study:

  • To investigate if apolipoprotein E (apoE) modulates neuronal response to glutamate excitotoxicity.
  • To explore the potential neuroprotective mechanisms of apoE in the context of excitotoxicity.

Main Methods:

  • Primary neuronal glial cultures and a neuronal cell line were utilized.
  • Cells were exposed to apolipoprotein E (apoE) before N-methyl-D-aspartate (NMDA) receptor activation.
  • Calcium influx was measured and compared to NMDA receptor antagonist MK-801.

Related Experiment Videos

Main Results:

  • Apolipoprotein E (apoE) demonstrated partial protective effects against NMDA-induced excitotoxicity in both neuronal models.
  • At neuroprotective concentrations, apoE did not fully block NMDA-induced calcium influx compared to MK-801.
  • These findings suggest apoE's protective role is not solely mediated by blocking calcium influx.

Conclusions:

  • Apolipoprotein E (apoE) may protect the central nervous system during ischemia by mitigating glutamate excitotoxicity.
  • The partial protective effect of apoE highlights its complex role in neuronal injury and repair.
  • Further research is warranted to fully elucidate apoE's therapeutic potential in stroke and other neurological disorders.